Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02337530
Title Selumetinib in Patients Receiving Pemetrexed and Cisplatin in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Abbotsford Centre Abbotsford British Columbia V2S 0C2 Canada Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
Regional Health Authority B, Zone 2 Saint John New Brunswick E2L 4L2 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Cancer Centre of Southeastern Ontario at Kingston Kingston Ontario K7L 5P9 Canada Details
Lakeridge Health Oshawa Oshawa Ontario L1G 2B9 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
Mount Sinai Hospital Toronto Ontario M5G 1X5 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
CHUM - Hopital Notre-Dame Montreal Quebec H2L 4M1 Canada Details
*Shaded cells indicate that there was no data available from for the field